Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor .beta.
Patent Number: 5674843
Date of First Priority Issue: Thursday September 2nd, 1993
Date Issued: Tuesday October 7th, 1997
Assignee: Celtrix Pharmaceuticals, Inc. (Santa Clara, CA)
Inventor: Carlino, Joseph A. (San Leandro, CA)
From Class: Mobilization
Comments: No comments
This patent teaches that the stem cell inhibitory compound TGF-beta may be administered for the purpose of mobilization.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.